Qube Research & Technologies Ltd - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 242 filers reported holding TG THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$2,549,684
+177.1%
215,527
+38.8%
0.01%
+180.0%
Q3 2022$920,000
-3.0%
155,321
-30.4%
0.01%
-28.6%
Q2 2022$948,000
+4.3%
223,088
+851.8%
0.01%
-30.0%
Q2 2021$909,000
+168.1%
23,438
+34.6%
0.01%
+100.0%
Q2 2020$339,000
+32.4%
17,413
-24.6%
0.01%
-37.5%
Q4 2019$256,00023,0950.01%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders